Form 4: Tandem Diabetes Care Director Exercises Stock Options

Myoungil Cha, a director at Tandem Diabetes Care, exercised stock options and now directly owns 7,563 shares of common stock.

Summary

• On June 17, 2024, Myoungil Cha, a director of Tandem Diabetes Care Inc., executed a transaction involving the company's stock.
• Cha exercised restricted stock units (RSUs), converting them into 1,749 shares of common stock at a price of $45.33.
• Following this transaction, Cha directly owns 7,563 shares of Tandem Diabetes Care Inc.
• The RSUs were awarded on June 15, 2022, under the company's 2013 Stock Incentive Plan and vested in equal annual installments over three years.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a standard disclosure of a director exercising stock options, which doesn't inherently indicate positive or negative sentiment.

Positives

• The director's exercise of stock options could be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC when company insiders, like directors, make transactions in their company's stock. It provides transparency to the market about insider activity.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it is a routine insider transaction.

Key Dates